Información de la revista
Vol. 32. Núm. 1.
Páginas 72-76 (Enero - Febrero 2018)
Respuestas rápidas
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
No disponible
Vol. 32. Núm. 1.
Páginas 72-76 (Enero - Febrero 2018)
Brief original article
Open Access
Informed participation in the Valencian Community Colorectal Cancer Screening Programme from a gender perspective
Participación informada en el Programa de Prevención del Cáncer Colorrectal de la Comunidad Valenciana desde una perspectiva de género
Visitas
8524
Ana Molina-Barcelóa,b,
Autor para correspondencia
molina_anabar@gva.es

Corresponding author.
, Rosana Peiró-Péreza,c,d, Mercedes Vanaclochaa, Guillermo Vallésa, Laura Guaitae, Dolores Salasc
a Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO, Valencia, Spain
b Universidad de Valencia, Valencia, Spain
c Dirección General de Salud Pública (DGSP), Valencia, Spain
d CIBER de Epidemiología y Salud Pública (CIBERESP), Spain
e Freelance Sociologist, Valencia, Spain
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (2)
Table 1. Descriptive and bivariate analysis of the explanatory variables by participation in CRCSP and being informed. Valencian Community, 2009-2010.
Table 2. Multivariate logistic regression models of response variables Participation in CRCSP and Being informed for the total sample and by sex. Valencian Community, 2009-2010.
Mostrar másMostrar menos
Material adicional (1)
Abstract
Objective

To examine the factors that influence informed participation in a Colorectal Cancer Screening Programme (CRCSP) from a gender perspective.

Methods

Cross-sectional telephone survey directed to men and women invited to participate (2009-2010) in the Valencian Community CRCSP (Spain). Sample size: 785 subjects. Outcome variables: participation in CRCSP and being informed. Bivariate and multivariate analysis using logistic regression models (95% confidence interval [95%CI], p <0.05).

Results

Being a woman (odds ratio [OR]: 1.52; 95%CI: 1.06-2.19), receiving information from a general practitioner (OR: 1.64; 95%CI: 1.05-2.55) and being informed (OR: 1.54; 95%CI: 1.08-2.21) are related to participation. Men are more likely to participate if they live with a partner (OR: 6.26; 95%CI: 1.82-21.49); and are more informed if they have family responsibilities (OR: 2.53; 95%CI: 1.39-4.63).

Conclusion

Information about CRCSP, involving primary health care professionals and including specific actions directed at men and at women, could contribute to improve informed participation with a gender equity perspective.

Keywords:
Early detection of cancer
Colorectal neoplasm
Gender identity
Patient participation
Informed decision making
Resumen
Objetivo

Examinar los factores que influyen en la participación informada en un Programa de Prevención del Cáncer Colorrectal (PPCCR) desde una perspectiva de género.

Métodos

Estudio transversal mediante encuesta telefónica a hombres y mujeres invitados a participar (2009-2010) en el PPCCR de la Comunidad Valenciana. Tamaño muestral: 785 sujetos. Variables resultado: participación en el PPCCR y estar informado/a. Análisis bivariado y multivariado mediante modelos de regresión logística (intervalo de confianza del 95% [IC95%], p <0,05).

Resultados

Ser mujer (odds ratio [OR]: 1,52; IC95%: 1,06-2,19), recibir información del médico/a de atención primaria (OR: 1,64; IC95%: 1,05-2,55) y estar informado/a (OR: 1,54; IC95%: 1,08-2,21) está relacionado con la participación en el PPCCR. Los hombres tienen más probabilidad de participar en el PPCCR si viven en pareja (OR: 6,26; IC95%: 1,82-21,49), y están más informados si tienen responsabilidades familiares (OR: 2,53; IC95%: 1,39-4,63).

Conclusión

Informar sobre el PPCCR, con implicación de los profesionales de atención primaria, mediante acciones específicas para hombres y mujeres, puede contribuir a mejorar la participación informada desde una perspectiva de equidad de género.

Palabras clave:
Detección precoz del cáncer
Cáncer colorrectal
Género
Participación
Toma de decisión informada
Texto completo
Introduction

Participation in colorectal cancer screening programmes (CRCSP) has been shown to have benefits for health but also adverse effects.1 Informing the population of both benefits and harms of screening helps to encourage informed decision-making, however the foundations for doing so are yet to be established.2

Informed decision-making in health has been defined by several authors3,4 and despite the fact that no validated measurement exists,5 the majority agree that it must be based on accessible, up-to-date, relevant and unbiased information about the disease and the benefits and risks of making the decision.

Informed participation is considered in this study as the relationship between participation in CRCSP and the level of knowledge of the benefits and harms of participating in such programmes. In order to increase both participation and informed decision-making in these programmes (from now on informed participation), on the basis of European recommendations6 knowledge of the factors that influence both participation and knowledge is of the utmost importance. There is much evidence supporting that men participate less than women in such programmes7 but little is known about if they are also less informed and if this influences their participation.

Within the context of the Valencian Community (VC, Spain) Colorectal Cancer Screening Programme (CRCSP) a study was performed to evaluate the factors influencing participation. Gender inequalities in the reasons for participating in that programme have been identified.8 This paper aims to further examine the factors that influence informed participation in the VC CRCSP from a gender perspective.

MethodsDesign and subjects

Cross-sectional survey by means of a telephone questionnaire was performed. The population study were men and women aged from 50 to 74 years old invited to participate, including initial and successive invitations, in the VC CRCSP between October 2009 and September 2010.

A 23 question ad hoc questionnaire was designed (available at Annex I, online supplementary material).

Stratified random sampling was conducted by simple allocation depending on participation or not in the programme (5% error, 5% accuracy, 50% proportion), and sampling by quotas for sex and age. A total of 785 (401 CRCSP participants and 384 non-participants) questionnaires were administered and the response rate was 59.61%

A more detailed description of the study methodology and the invitation process of the VC CRCSP may be found in the study by Molina-Barceló et al.8

Variables

The outcome variables are participation in the CRCSP and being informed (both of the CRC disease as well as the CRCSP). Participation refers to previous performance of the fecal occult blood test (according to the information included in the programme's database); and being informed is defined according to the questionnaire responses by having a medium/high knowledge level (KL) (from 3 to 5 correct answers) on each of the specific dimensions: CRC risk factors (from question 11a to 11e), CRC symptoms (from 12a to 12e), CRCSP organizational issues (from 19a to 19e), CRCSP benefits (from 19f to 19g) and harms (from 19h to 19i) (Annex I, online supplementary material). The potential maximum score of being informed was 10 points and subjects were considered to be informed when scoring 5 or over, with the requirement that at least one correct answer must be obtained in questions related to the CRCSP benefits and harms (from 19f to 19i). Other variables related to information were: access to CRC and CRCSP information (questions 10 and 16 respectively) and general practitioner (GP) information (question 17d).

Explanatory variables are of socio-economic characteristics, relatives and friends with cancer and prevention practices, perceptions, beliefs and attitudes, and information access and KL. The construction of social class variable was made taking into account the abbreviated classification system of the Spanish Society of Epidemiology9 and integrating the concept of dominant social class.10

Data collection

Data was collected in 2011. Verbal informed consent was obtained from all participants in the study. The study was approved by the Clinical Research Ethics Committee of the General Directorate of Public Health of VC.

Data analysis

A descriptive analysis of the participation in CRCSP and of being informed was performed, using the chi-squared test, in order to identify the independent association with the explanatory variables.

Logistic regression models were adjusted for participation in CRCSP and for being informed, stratifying by sex, including the explanatory variables that showed statically association in the bivariate analysis and those that provided a model with greater prediction.

The results of the chi-squared analysis were shown in terms of p-value, and the logistical regression analysis in terms of odds ratios (OR) and 95% confidence interval (95%CI). The level of significance considered was of 0.05.

Results

The majority of the study subjects were participants in the CRCSP (51.1%, n=401), 55.2% of whom were women (n=229) and 46.5% men (n=172). The majority were uninformed (56.5%, n=435), 52.2% of whom were women (n=212) and 61.3% men (n=223).

Table 1 shows that both participating in CRCSP along with being informed are statistically related (p <0.05). The variables sex, education level, participation in the Breast Cancer Screening Programme (BCSP) (women only), future intention to participate, valuation of the information received and GP information are related both to participation as well as to being informed.

Table 1.

Descriptive and bivariate analysis of the explanatory variables by participation in CRCSP and being informed. Valencian Community, 2009-2010.

    Participation in CRCSP  Being informed 
    No, n (%)  Yes, n (%)  No, n (%)  Yes, n (%) 
Socio-economic characteristics
SexMen  198 (53.5)  172 (46.5)    223 (61.3)  141 (38.7)   
Women  186 (44.8)  229 (55.2)  0.014  212 (52.2)  194 (47.8)  0.012 
Age50-59  194 (53.7)  167 (46.3)    188 (52.8)  168 (47.2)   
60 and over  189 (44.7)  234 (55.3)  0.011  246 (59.6)  167 (40.4)  0.056 
Geographical areaaRural  55 (39.0)  86 (61.0)    88 (63.3)  51 (36.7)   
Urban  328 (51.0)  315 (49.0)  0.010  346 (54.9)  284 (45.1)  0.071 
Education levelbHigh  126 (54.3)  106 (45.7)    109 (47.8)  119 (52.2)   
Low  257 (46.6)  295 (53.4)  0.047  325 (60.1)  216 (39.9)  0.002 
Living with a partnerNo  50 (64.1)  28 (35.9)    36 (46.8)  41 (53.2)   
Yes  296 (46.0)  347 (54.0)  0.003  362 (57.4)  269 (42.6)  0.076 
Social classcManual  160 (46.0)  188 (54.0)    209 (61.7)  130 (38.3)   
Non manual  153 (45.9)  180 (54.1)  0.994  166 (60.3)  164 (49.7)  0.003 
Employment statusInactived  249 (46.5)  287 (53.5)    299 (57.3)  223 (42.7)   
Active  100 (52.4)  91 (47.6)  0.161  88 (46.1)  103 (53.9)  0.008 
Family responsibilitiesNo  275 (49.4)  282 (50.6)    325 (59.5)  221 (40.5)   
Yese  69 (44.5)  86 (55.5)  0.285  67 (43.8)  86 (56.2)  0.001 
Relatives and friends with cancer and prevention practices
Relatives and friends with cancerNo  73 (46.2)  85 (53.8)    107 (70.9)  44 (29.1)   
Yes  311 (49.8)  314 (50.2)  0.424  326 (52.8)  291 (47.2)  <0.001 
Prevention practice levelfLow  62 (48.8)  65 (51.2)    85 (68.0)  40 (32.0)   
High  317 (49.0)  330 (51.0)  0.971  345 (54.0)  294 (46.0)  0.004 
Participation in BCSP (women only)No  22 (62.9)  13 (37.1)    27 (79.4)  7 (20.6)   
Yes  160 (43)  212 (57)  0.024  183 (49.7)  185 (50.3)  0.001 
Perceptions, beliefs and attitudes
CRC vulnerability perceptionLow  71 (56.8)  54 (43.2)    58 (46.8)  66 (53.2)   
Highg  40 (65.6)  21 (34.4)    38 (54.3)  32 (45.7)  0.066 
Don’t know  264 (46.8)  300 (53.2)  0.060  324 (58.2)  233 (41.8)   
Future intention to participate in CRCSPNoh  162 (78.6)  44 (21.4)    146 (71.9)  57 (28.1)   
Yes  217 (38.1)  352 (61.9)  <0.001  285 (50.6)  278 (49.4)  <0.001 
Self-perceived health statusiPoor  132 (47.5)  146 (52.5)    155 (56.8)  118 (43.2)   
Good  250 (49.7)  253 (50.3)  0.552  279 (56.4)  216 (43.6)  0.912 
Access to information and KL of CRC and CRCSP
Access to CRC informationNo  54 (60.7)  35 (39.3)         
Yes  327 (47.3)  364 (52.7)  0.018       
Access to CRCSP informationNo  175 (73.8)  62 (26.2)         
Yes  208 (38.4)  334 (61.6)  <0.001       
Valuation of information receivedInsufficient  135 (71.1)  55 (28.9)    138 (73.4)  50 (26.6)   
Sufficient  240 (41.3)  341 (58.7)  <0.001  289 (50.3)  285 (49.7)  <0.001 
GP informationNoh  333 (53.5)  290 (46.5)    361 (58.6)  255 (41.4)   
Yes  49 (31.6)  106 (68.4)  <0.001  74 (48.1)  80 (51.9)  0.018 
CRC risk factors KLjLow  173 (53.2)  152 (46.8)         
High  205 (45.8)  243 (54.2)  0.040       
CRC symptoms KLjLow  148 (53.4)  129 (46.6)         
High  230 (46.4)  266 (53.6)  0.060       
CRCSP organizational issues KLjLow  189 (68.5)  87 (31.5)         
High  192 (38.6)  305 (61.4)  <0.001       
CRCSP benefits and harms KLjLow  209 (63.5)  120 (36.5)         
High  172 (38.7)  273 (61.3)  <0.001       
Being informedNo  241 (55.4)  194 (44.6)         
Yes  139 (41.5)  196 (58.5)  <0.001       

BCSP: breast cancer screening programme; CRC: colorectal cancer; CRCSP: colorectal cancer screening programme; GP: general practitioner; KL: knowledge level.

a

Rural (≤10.000 inhabitants), urban (>10.000).

b

Low (unable and can read or write/primary and lower secondary school), high (upper secondary/post-secondary/tertiary education).

c

Manual (IVa, IVb, V and VI- abbreviated classification of Spanish Epidemiology Society), non-manual (I, II, IIIa, IIIb, IIIc).

d

Unemployed/retired/housework.

e

Living with persons <15 or >75 years old.

f

Low (≤1 prevention activities), high (≥2 activities).

g

Moderate/high.

h

No/don’t know.

i

Poor (fair/poor/very poor), good (very good/good).

j

Low (no knowledge/low), high (moderate/high).

The multivariate analysis (Table 2) shows that there is a greater probability of participation by women (OR: 1.52; 95%CI: 1.06-2.19), being 60 and over (OR: 1.64; 95%CI: 1.14-2.36), living with a partner (OR: 2.12; 95%CI: 1.18-3.79), with future intention to participate in CRCSP (OR: 6.51; 95%CI: 4.13-10.25), considering information to be sufficient (OR: 2.54; 95%CI: 1.65-3.91), receiving GP information (OR:1.64; 95%CI: 1.05-2.55) and being informed (OR: 1.54; 95%CI: 1.08-2.21). Analyses stratified by sex show that men, unlike women, are more likely to take part in screening if they are 60 and over (OR: 2.39; 95%CI: 1.36-4.20) and live with a partner (OR: 6.08; 95%CI: 1.80-20.48). With regards being informed, the probability increases in the case of women (OR: 1.49; 95%CI: 1.06-2.09), people with family responsibilities (OR: 2.01; 95%CI: 1.35-2.99), having relatives and friends with cancer (OR: 2.01; 95%CI: 1.30-3.10), high level of prevention practices (OR: 1.73; 95%CI: 1.10-2.71), had participated in CRCSP (OR: 1.82; 95%CI: 1.29-2.58) and of the opinion that the information conveyed is sufficient (OR: 2.03; 95%CI: 1.35-3.08); and decreased if people have low education level (OR: 0.63; 95%CI: 0.44-0.91). Men, unlike women, are more informed if they have family responsibilities (OR: 2.53; 95%CI: 1.39-4.63) and consider the information conveyed to be sufficient (OR: 2.74; 95%CI: 1.46-5.14).

Table 2.

Multivariate logistic regression models of response variables Participation in CRCSP and Being informed for the total sample and by sex. Valencian Community, 2009-2010.

    OV: Participation in CRCSP, OR (95%CI)OV: Being informed, OR (95%CI)
    Total  Women  Men  Total  Women  Men 
Sex  Men 
  Women  1.52 (1.06-2.19)a      1.49 (1.06-2.09)a     
Age  50-59 
  60 and over  1.64 (1.14-2.36)a  1.22 (0.73-2.06)  2.39 (1.36-4.20)a  0.83 (0.59-1.16)  0.60 (0.37-0.95)a  1.23 (0.72-2.08) 
Geographical area  Rural 
  Urban  0.67 (0.41-1.08)  0.82 (0.42-1.60)  0.56 (0.27-1.16)  1.27 (0.81-2.01)  1.60 (0.87-2.95)  0.89 (0.44-1.81) 
Education level  High 
  Low  1.26 (0.85-1.87)  1.60 (0.86-2.95)  1.06 (0.61-1.83)  0.63 (0.44-0.91)a  0.66 (0.38-1.16)  0.66 (0.40-1.09) 
Living with a partner  No 
  Yes  2.12 (1.18-3.79)a  1.25 (0.59-2.64)  6.08 (1.80-20.48)a  0.78 (0.46-1.32)  0.72 (0.36-1.44)  0.80 (0.33-1.92) 
Family responsibilities  No 
  Yes        2.01 (1.35-2.99)a  1.67 (0.96-2.90)  2.53 (1.39-4.63)a 
Relatives and friends with cancer  No 
  Yes  0.48 (0.30-0.76)a  0.44 (0.20-0.96)a  0.51 (0.28-0.93)a  2.01 (1.30-3.10)a  2.48 (1.24-4.94)a  1.77 (0.99-3.15) 
Prevention practice level  Low 
  High        1.73 (1.10-2.71)a  0.53 (0.27-1.05)  1.78 (0.96-3.33) 
Participation in CRCSP  No 
  Yes        1.82 (1.29-2.58)a  1.80 (1.11-2.93)a  1.69 (0.99-2.89) 
Participation in BCSP (women only)  No 
  Yes    1.79 (0.67-4.75)      2.61 (0.97-7.03)   
Future intention to participate in CRCSP  No 
  Yes  6.51 (4.13-10.25)a  9.73 (5.20-18.23)a  3.58 (1.79-7.16)a       
Valuation of information received  Insufficient 
  Sufficient  2.54 (1.65-3.91)a  2.84 (1.54-4.22)a  2.35 (1.23-4.50)a  2.03 (1.35-3.08)a  1.56 (0.87-2.78)  2.74 (1.46-5.14)a 
GP information  No 
  Yes  1.64 (1.05-2.55)a  1.58 (0.81-3.07)  1.65 (0.88-3.08)  1.34 (0.89-2.01)  1.47 (0.82-2.63)  1.24 (0.69-2.23) 
Being informed  No       
  Yes  1.54 (1.08-2.21)a  1.36 (0.80-2.30)  1.63 (0.96-2.75)       

BCSP: breast cancer screening programme; 95%CI: 95% confidence interval; CRCSP: colorectal cancer screening programme; GP: general practitioner; OR: odds ratio; OV: outcome variable.

a

p <0.05.

Discussion

Being a woman, receiving information from a general practitioner and being informed of the disease and the programme are related to participation in CRCSP.

The gender analysis shows that women participate more in CRCSP than men, with similar results in the majority of studies.7,11 Therefore “inverse prevention”12 is taking place in the VC CRCSP, since there is greater incidence and mortality from CRC among men.13 The influence of traditional gender roles in health, such as greater self-care in women and poorer perception of vulnerability among men,14 could be an explanation of these gender inequalities in participation.

This study contributes to improving knowledge about gender differences in the factors related to participation in CRCSP programmes. Men are more likely to participate if they live with a partner, according to the results of other studies that point out the dependence of men on their female partners when carrying out the cancer screening tests.15. And women tend to participate more if they have previously attended BCSP, in line with other studies.16 A positive experience in BCSP and the characteristics of these women may be possible explanations of this relationship. Collaboration between both cancer screening programmes to enhance participation of women and men would be advisable.

The results of this study show a relationship between knowledge about the disease and the programme, and participation in CRCSP. Whereas some studies had not found this relationship17 others had underlined low knowledge as one of the obstacles to participation.18 This relationship should be interpreted with caution as knowledge was measured after participation in the programme and could be conditioned by this. But, in any case, it supports the importance of promoting informed participation. This study also shows that receiving GP information increase participation, highlighting the importance of primary health care involvement in promoting such programmes.19

Finally, the study shows that women, people with high educational level, and having family responsibilities are better informed of CRCSP, with the latter situation statically significant only for men. Gender equity in family care responsibilities could contribute to increasing CRCSP knowledge among men, and therefore to enhancing informed participation in such programmes.

Unbiased information about the CRC and screening programmes involving primary health care professionals, considering specific strategies directed at men and women could enhance informed participation with a gender equity perspective.

Editor in charge

Mª José López.

Transparency declaration

The corresponding author on behalf of the other authors guarantee the accuracy, transparency and honesty of the data and information contained in the study, that no relevant information has been omitted and that all discrepancies between authors have been adequately resolved and described.

What is known about the topic?

There is much evidence that men participate less than women in colorectal cancer screening programmes but little is known about if they are also less informed and if this influences their participation. Knowledge of the factors that influence informed participation from a gender perspective is not yet well known and therefore is of the utmost importance.

What does this study add to the literature?

Information and participation in colorectal cancer screening programs are interrelated. There are gender inequalities in participation as well as in the access of information, in general showing men to be in an unequal position. Information strategies considering specific actions directed at men and women, could contribute to improving informed participation with a gender equity perspective.

Authorship contributions

A. Molina-Barceló, R. Peiró-Pérez and D. Salas designed the study. The data was collected by L. Guaita. M. Vanaclocha and G. Vallés performed the analysis of the data. A. Molina-Barceló drafted the manuscript and all the authors contributed to the interpretation of the result, critically revised the work and approved the final version to be published.

Funding

This study has received a grant of 4,950 € from the Regional Health Authorities of the Valencian Community through the call for Grants for the Fomento de la Investigación Sanitaria en la Comunitat Valenciana (Ref. number: 053/2010).

Conflicts of interest

None.

References
[1]
W. Holland, S. Stewart, C. Masseria.
Policy brief: screening in Europe.
World Health Organization, European Observatory on Health Systems and Policies, (2006),
[2]
G. Gigerenzer, J. Mata, R. Frank.
Public knowledge of benefits of breast and prostate cancer screening in Europe.
J Natl Cancer Inst., 101 (2009), pp. 1216-1220
[3]
B.K. Rimer, P.A. Briss, P.K. Zeller, et al.
Informed decision making: what is its role in cancer screening?.
Cancer., 101 (2004), pp. 1214-1228
[4]
S.K. Smith, J.M. Simpson, L.J. Trevena, et al.
Factors associated with informed decisions and participation in bowel cancer screening among adults with lower education and literacy.
Med Decis Making., 34 (2014), pp. 756-772
[5]
R.G. Jepson, J. Hewison, A.G. Thompson, et al.
How should we measure informed choice? The case of cancer screening.
J Med Ethics., 35 (2005), pp. 192-196
[6]
J. Austoker, L. Giordano, P. Hewitson, et al.
Communication.
European guidelines for quality assurance in colorectal cancer screening and diagnosis., 1st ed.,
[7]
S. Javanparast, P. Ward, G. Young, et al.
How equitable are colorectal cancer screening programs which include FOBTs.
A review of qualitative and quantitative studies. Prev Med., 50 (2010), pp. 165-172
[8]
A. Molina-Barceló, D. Salas-Trejo, R. Peiró-Pérez, et al.
Reasons for participating in the Valencian Community Colorectal Cancer Screening Programme by gender, age, and social class.
Rev Esp Enferm Diag., 106 (2014), pp. 439-447
[9]
C. Álvarez-Dardet, J. Alonso, A. Domingo, et al.
La medición de la clase social en ciencias de la salud. Informe de un grupo de trabajo de la Sociedad Española de Epidemiología.
SG Editores, (1995), pp. 117
[10]
C. Borrell, I. Rohlfs, L. Artazcoz, et al.
Desigualdades en salud según la clase social en las mujeres. ¿Cómo influye el tipo de medida de la clase social?.
Gac Sanit., 18 (2004), pp. 75-82
[11]
C. von Wagner, G. Baio, R. Raine, et al.
Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.
Int J Epidemiol., 40 (2011), pp. 712-718
[12]
J. Tudor Hart.
The inverse care law.
[13]
J. Ferlay, I. Soerjomataram, R. Dikshit, et al.
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Int J Cancer., 136 (2015), pp. E359-E386
[14]
Velasco S. Recomendaciones para la práctica clínica con enfoque de género. Madrid: Observatorio de Salud de la Mujer, Dirección General de la Agencia de Calidad del Sistema Nacional de Salud, Ministerio de Sanidad y Política Social; 2009.
[15]
L.C. Kobayashi, J. Wardle, C. von Wagner.
Limited health literacy is a barrier to colorectal cancer screening in England: evidence from the English Longitudinal Study of Ageing.
Prev Med., 61 (2014), pp. 100-105
[16]
M.D. Wirth, H.M. Brandt, H. Dolinger, et al.
Examining connections between screening for breast, cervical and prostate cancer and colorectal cancer screening.
Colorectal Cancer., 3 (2014), pp. 253-263
[17]
A. Steckelberg, C. Hülfenhaus, B. Haastert, et al.
Effect of evidence based risk information on informed choice in colorectal cancer screening: randomised controlled trial.
BMJ., 342 (2011), pp. d3193
[18]
A. Molina-Barceló, D. Salas Trejo, R. Peiró-Pérez, et al.
To participate or not? Giving voice to gender and socio-economic differences in colorectal cancer screening programmes.
Eur J Cancer Care., 20 (2011), pp. 669-678
[19]
C. Senore, J. Inadomi, N. Segnan, et al.
Optimising colorectal cancer screening acceptance: a review.
Gut., 64 (2015), pp. 1158-1177
Copyright © 2016. SESPAS
Idiomas
Gaceta Sanitaria
Opciones de artículo
Herramientas
Material suplementario
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?